Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Vemurafenib for Advanced Cancers with BRAF V600 Mutations
Recruiting1 awardPhase 2
Tampa, Florida
This trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600 mutations.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.